In Collaboration With:


Paul Hutchinson began working in flow cytometry in 1983 at the Peter MacCallum Cancer Institute in Melbourne. In this lab, flow cytometry was used for clinical and research work, including the diagnosis of AIDS patients at the beginning of the HIV epidemic and early research on the isolation of hemopoietic stem cells. In 1992 Paul joined the Clinical Immunology department at Monash Medical Centre and was in charge of the core flow cytometry facility. In February 2008, he was appointed the head of the Unidade de Citometria de Fluxo at the Instituto de Medicina Molecular in Lisbon, Portugal. Since July 2009 Paul has been in charge of the core flow cytometry facility at the Immunology Programme of the National University of Singapore. 


Dr. Vivek Tanavde obtained his Ph.D. from the Cancer Research Institute, Mumbai (1999) in Applied Biology. From 1999 to 2002 he was a post-doctoral fellow at the Sidney Kimmel Cancer Centre, Johns Hopkins University working on the expansion of hematopoietic stem cells. He returned to India in 2002 and was heading the Hematopoietic Stem Cell Lab at Reliance Life Sciences, Mumbai. In 2006, he joined the Bioinformatics Institute, Singapore as a Research Scientist in the Genome & Gene Expression Data Analysis Division, where he was a Principal Investigator until Oct 2016. Most of his work has focused on developing protocols for expansion and targeted differentiation of hematopoietic and mesenchymal stromal cells. His current research focuses on the use of bioinformatics and systems biology tools to understand mesenchymal stromal cell biology and differentiation. He has recently joined Ahmedabad University as an Associate Professor.


Anis Larbi holds a Ph.D. in Immunology and is a Principal Investigator at the Singapore Immunology Network. He is also the head of the Flow Cytometry Platform at SIgN/A*STAR. He is a Marylou Ingram Emeritus Scholar and active in ISAC activities. His primary research interest is the biology of aging with a focus on immunity and inflammation.


Adrian Smith has been the manager of the Cytometry and Imaging Facility at the Centenary Institute since 2004. He has overseen the growth of the facility from three flow cytometers in 2004 to now include over thirty instruments. The cytometric capabilities are operated as the Sydney Cytometry Core Research Facility - a joint initiative of the Centenary Institute and the University of Sydney - of which Adrian serves at the Technical Director. Adrian was the president of the Australasian Cytometry Society (ACS) from December 2010 to November 2014 and member of the Council of the International Society for the Advancement of Cytometry from 2014 to 2018. Adrian teaches imaging and cytometry on a regular basis to both researchers and technical staff and he has presented workshop and tutorials for many groups including CSIRO, AFCG/ACS, QIMR, ASI, ISCT and ISAC (CYTO conference).


Dr. David Westerman is a University of Melbourne graduate with dual fellowships and has held his current position as Head of Haematopathology at Peter MacCallum Cancer Centre, since 2000. He is Deputy Director of the Dept of Pathology, Chair of the Transfusion Medicine Committee and holds honorary appointments with the University of Melbourne at St Vincent’s Hospital Clinical School, and the Sir Peter MacCallum Dept of Oncology. He is a member of the RCPA immunophenotyping committee. He has broad clinical and laboratory academic interests including teaching, flow cytometry, molecular hematology and biomarkers which are reflected by over 100 peer-reviewed publications.


Andrea Cossarizza received his degree in Medicine and Surgery from the University of Padova, then his Ph.D. from Oncology at the University of Bologna and the University of Modena, and the Specialization in Clinical Pathology and Immunohematology from the University of Modena and Reggio Emilia. Since he was a medical student, he visited the Basel Institute of Immunology and then NYU. After some periods in different Institutes (Charing Cross Sunley Res. Ctr., London; Univ. Cochin, Paris; UCLA), in 1998 he became Associate Professor of General Pathology and Immunology at the University of Modena and Reggio Emilia, and in 2010 was appointed Full Professor.

As of March 10th, 2019, Dr. Cossarizza has published 321 papers in peer-reviewed international journals (PubMed). He is one of the most quoted opinion leaders in the field of Cytometry, member of several advisory boards, and President of the International Society for Advancement of Cytometry (ISAC) that counts thousands of members in 52 different countries.


Kovit Pattanapanyasat received his B.Sc and MSc in Biochemistry, (1974, 1977) from the Chulalongkorn University, Bangkok, Thailand.  He received a Dip. Bio. Med. Method, (1985) and a Ph.D. in Haematology (1987) from the University of Wales College of Medicine, Cardiff, the U.K. He has been on the Faculty of Medicine Siriraj Hospital, Mahidol University since 1987. He was appointed as a Professor in 1997 and is now Mahidol University’s Emeritus Professor and head of the Siriraj Center of Research Excellence in Microparticle and Exosome in Diseases (SiCORE MED) at the Department of Research and Development, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.


Olga Zharkova did her Ph.D. in immunology in the lab of Anna-Marie Fairhurst, in Singapore Immunology Network studying the role of the innate immune system in the onset of autoimmunity. In this lab, flow cytometry was used daily for work with human and murine samples. Since that time there was no rapid and robust method for NETosis quantification Olga and colleagues developed a simple, rapid method to quantify NETs in cultured neutrophils or whole blood. Following successful completion of her Ph.D., Olga moved on to NUS Immunology program to study interactions of influenza virus with the murine immune system. Currently, Olga is working in the cardiovascular research institute in Singapore, studying tissue immunology, which was named as the main trend in the immunology of XXI century by Prof. Abbas.


Dr. Lee Shir Ying is senior consultant hematologist in the Department of Laboratory Medicine, National University Hospital (NUH), and National University Cancer Institute, Singapore. The NUH flow cytometry laboratory adopted the EuroFlow standardization and diagnostic approach for leukemia and lymphoma immunophenotyping in 2012 and regularly subscribes to the College of American Pathologists and EuroFlow external quality programs. Besides her clinical commitments, she also serves as teaching core faculty of the National University Health System hematology residency program, assistant professor in the Yong Loo Lin School of Medicine of the National University of Singapore, and current chair of the hospital transfusion committee. Her interests are in flow cytometry, diagnostic hematology, transfusion medicine, and benign hematology conditions. As such, she has been engaged in talks and workshops on clinical flow cytometry both in Singapore and the South-East Asian region.


Dr. Paresh Jain is a hemat-oncopathologist currently working as Associate Director, BD Biosciences Clinical Solutions Platform, (Greater Asia) at Becton Dickinson Holdings Pte Ltd, Singapore. Dr. Jain qualified as M.D. (Pathology) from Grant Medical College, University of Bombay, India and trained in hemato-oncopathology (blood cancer pathology) at the All India Institute for Medical Sciences (AIIMS), New Delhi and at The Royal Marsden NHS Trust Hospital, London.

He worked as Assistant Professor at AIIMS, New Delhi (2001-2005). In 2005 he joined Biosciences Division of Becton Dickinson Pvt Ltd, India as Scientific Advisor. Dr. Paresh has more than 35 national/international publications and has organized and/or joined as faculty in more than 100 CMEs/workshops/ training programs on clinical and research applications of flow cytometry. He is an active member of the ISAC’s Live Education Task Force and a founder member of The Cytometry Society, India. 


Zosia Maciorowski received her B.Sc. in Microbiology from McGill University in Montreal and M.A. in Biology from Wayne State University in Detroit. For the last 24 years, she has been responsible for the Flow Cytometry Core Facility at the Curie Institute in Paris, France.  Zosia is also the Co-Chair of the Education Committee of International Society for Advancement of Cytometry (ISAC) and Co-Chair of the Live Education Task Force.  She has participated in international flow cytometry workshops organized by the Live Education Task Force of ISAC in ASEAN Countries, China, India, Europe, and the US. 


Geoffrey Osborne is Director of Special Order Research Products for BD Biosciences, based San Jose, CA, USA.  He leads a team focused on meeting customer needs by engineering technology advances to modify flow cytometers to fit unique roles. Prior to taking his current role, he was Director of Flow Cytometry for both Queensland Brain Institute and the Australian Institute for Bioengineering and Nanotechnology, at the University of Queensland, Brisbane, Australia for 13 years. In this position, Mr. Osborne leads a team that provided crucial cell sorting and analysis services to researchers both within QBI and across the broader university. 

Mr. Osborne holds a B.Sc. from The Australian National University (1993) and an Associate Diploma in Applied Biology from the Queensland University of Technology (1983)


H. Krishnamurthy obtained his PhD from the Manipal Academy of Higher Education, Manipal, India (1997) in Radiation Biology.  From 1997 to 2001, he underwent postdoctoral training at the Institute for Reproductive Medicine, Muenster, Germany: Institute for Clinical Research, Montreal, Canada and University of Iowa, Iowa, USA.  Later, he moved to Herbert Irving Comprehensive Cancer Center, Columbia University, New York, USA as Associate Research Scientist and Managing Director of the flow cytometry facility. At present, he is working as Scientific Officer ‘G’, Head of Research Facilities and In-charge of Central Imaging and Flow Cytometry at the National Centre for Biological Sciences, Tata Institute of Fundamental Research, Bangalore, India. He is a member of live education task force of the International Society for Advancement of Cytometry (ISAC). He has hosted the 9th and 11th Indo-US Cytometry workshops in Bangalore and participated in other workshops organized by the Asia Task Force of ISAC.


Dr. Ru is a US-Board certified pathologist with expertise in the areas of hematopathology and molecular pathology, as well as laboratory management. He attended medical school at Shandong Medical University in China, and obtained his PhD in cancer biology at State University of New York at Buffalo. He completed his pathology residency training from New England Medical Center and hematopathology fellowship from the University of Pennsylvania. After spending more than a decade in the United States, Dr. Ru returned to China in 2012. He currently holds the position of professor and Chair of Department of Pathology and Lab Medicine at the Institute of Hematology, Chinese Academy of Medical Sciences in Tianjin. His expertise and research has focused on the diagnosis of hematologic neoplasms, molecular analysis of various neoplastic and genetic disorders, single cell sequencing and application of artificial intelligence.